Medical Research Law & Policy Report® Index-Summary

NANOTECHNOLOGY

– Environmental issues

– Epidemiologic studies, NIOSH addresses, 200
– Framework for evaluating, FDA developing, 293
– International developments

– – Spain creates research lab, In Brief, 86; Spain and Portugal launch nanotech center, 529
– – U.K. review finds gaps in global research on environmental, health, and safety questions, 326

– Limited participation in EPA program reported, 51
– Md. funding cuts approved, 530
– Natl. Nanotechnology Initiative.

– – Agencies respond to criticism, 155
– – Collaboration planned by FDA and research institutions, 199
– – Reauthorization

See LEGISLATION, FEDERAL, HR 554, S 1482

– Responsible stewardship

See LEGISLATION, FEDERAL, HR 820

– Workshop planned, In Brief, 86

NATIONAL INSTITUTES OF HEALTH (NIH)

– Animal testing, NIH does not need “random source” of dogs and cats, report says, 424
– Appointments, Senate panel approves director, 519; Senate confirms, 556
– Bayh-Dole Act authority non-use, GAO reports, 522
– Biennial report released, 49
– Budget

– – Allergy and infectious disease institute to get stimulus funding, 392
– – Cancer proposal would double NCI funding, 141
– – FY2010 budget proposed, 361; House panel approves, 487
– – GOP leaders raise conflict of interest concerns, 229
– – Harkin (R-Iowa) ponders effect of stimulus funding after 2010, 391; Specter (R-Pa) and Harkin want more funding, 420
– – Omnibus bill

See LEGISLATION, FEDERAL, HR 1105

– – Recovery Act spending, HHS IG to report, 679
– – Stimulus funding at issue, 557
– – Top issue for 2009, 9
– – Use of funds, House hears testimony on stimulus package, 234

– Comparative effectiveness a top issue for 2009, 9
– Conflicts of interest

– – Grantees financial conflicts, NIH may expand regulations, 357
– – Revision of rules predicted, 97; proposed rule will expand monitoring, 311
– – Stimulus package, GOP leaders raise conflict of interest concerns, 229
– – Top issue for 2009, 9

– Director named, 482
– Grants

See GRANTS

– Pacemaker implanted as part of NIH experiment, failure-to-warn claim may proceed (D. Del.), 389
– Peer review a top issue for 2009, 9
– Project officer failed to show removal was retaliatory (D. Md.), 581
– Public access to research results, compliance problems continue, 152
– Risk management, GAO reports, 681
– Social science web site, In Brief, 53
– Translational research office urged by Parkinson's group, 668

NEVADA

– GINA rules, In Brief, 532

NEW HAMPSHIRE

– Human subject protection proposal, In Brief, 621

NEW JERSEY

– Angioplasty demonstration project, community hospital regulations upheld (N.J. Super. Ct.), 619
– Brain injury research grants, In Brief, 402
– Developmental disabilities research grants, In Brief, 593
– Spinal cord research grants, In Brief, 287; announced, In Brief, 712

NEW MEXICO

– Genetic discrimination, In Brief, 497

NEW YORK

– Egg donor compensation, panel approves, 496

NIGERIA

– Trovan clinical trial claims

– – Hearing planned on claim that Pfizer tried to circumvent victims' attorneys (Conn. Super. Ct.), 362
– – Jurisdiction, claims may be tried in U.S. (2nd Cir.), 73; (U.S., rev sought), 516
– – Kano settles with Pfizer, 513
– – Settlement reported, 117; settlement said near, 276

NIH

See NATIONAL INSTITUTES OF HEALTH (NIH)

NORTH DAKOTA

– GINA rules, In Brief, 532